<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03330210</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL17_0230</org_study_id>
    <nct_id>NCT03330210</nct_id>
  </id_info>
  <brief_title>Left Atrial Appendage Occlusion Guided by 3D Printing</brief_title>
  <acronym>LAA-PrintRegis</acronym>
  <official_title>National Longitudinal Registry for Mid-Term Clinical Outcome And Procedure Efficacy Evaluation In Using A Novel Preprocedural Planning Method For Left Atrial Appendage Occlusion Guided By 3D Printing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hôpital Privé Les Franciscaines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rangueil Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique Pasteur, Toulouse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique du Millénaire - Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique Saint Pierre - Perpignan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Dupuytren</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital St. Joseph, Marseille, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Georges Pompidou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left atrial appendage closure (LAAC) was approved by the ESC guidelines as a stroke
      prevention alternative to warfarin for patients with nonvalvular atrial fibrillation in
      patients at high risk of bleeding (IIbB).

      Although the overall LAAC benefice, in term of prevention of stroke or embolisme and
      decresing the anticoagulant-related risk of bleeding is already demonstrated, however the
      procedure success and safety, critically depends on understanding LAA anatomy and adequate
      pre-procedure planning.

      3D-printed patient-specific adaptive and flexible LA models have demonstrated in a previous
      study an improving in LAAO device sizing, a better pre-procedural planning of the optimal
      trans-septal puncture site, by incorporating all anatomical variations and an improuving
      patient outcomes by reducing procedure time and number of prostheses employed per patient.

      This technique is now used in several surgical centers in France and large prospective
      evaluation of the practice is necessary.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 3D printing has modified the LAAC practices with a preoperative time allowing an optimal
      preparation of the prosthesis. This technique is now used in several surgical centers and
      prospective evaluation of the practice is necessary.

      The objective of our research is to demonstrate the reduction of the operating time and
      number of prosthesis used per procedure when prior LAAC simulation testing and sizing is made
      on a 3D printed model.

      It is therefore a longitudinal research to monitor professional practices for the evaluation
      of a new preoperative approach.

      Procedures guided by 3Dprinted models will be compared (intention to treat population) in
      term of procedural parameters (procedure time, success rate, number of prosthesis per
      procedure) and procedural complication with prior Watchman study: post-FDA Approval US
      experience and national registries data. A second analysis (per protocol population) will be
      performed to compare patients with an informative utilization guided by 3D printed to those
      of the post-FDA Approval US experience and national registries.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>operating time</measure>
    <time_frame>During 1 day</time_frame>
    <description>mesure of operating time to Day 0 (J0)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of protheses</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease number of prothèses to Day 0 (J0)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implantation success rate</measure>
    <time_frame>During 1 day</time_frame>
    <description>increase implantation success rate at Day 0 (J0)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of periprosthetic leak</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease number of periprosthetic leak at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anasthesia time</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease of anasthesia time at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of scopy</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease time of scopy at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>irradiation dose</measure>
    <time_frame>1 day</time_frame>
    <description>decrease of irradiation dose (mGy.cm2) at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of Hospitalisation</measure>
    <time_frame>During 1 day</time_frame>
    <description>discharge and decrease of hospitalisation days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of recapture</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease number of recapture at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of off-axis prostheses</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease number of off-axis prosthèses at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of embolized prostheses</measure>
    <time_frame>During 1 day</time_frame>
    <description>decrease number of embolized prosthèses at Day 0 (J0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective complete occlusion of the auricle</measure>
    <time_frame>3 months</time_frame>
    <description>increase rate of Effective complete occlusion of the auricle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective complete occlusion of the auricle</measure>
    <time_frame>6 months</time_frame>
    <description>increase rate of Effective complete occlusion of the auricle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prosthesis trombosis</measure>
    <time_frame>12 months</time_frame>
    <description>rate of prosthesis trombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedural complications</measure>
    <time_frame>during procedure and within 30 days</time_frame>
    <description>analysis of complications (Stroke, transient ischaemic attack, peripheral embolism, Pericardial effusion and tamponade Bleeding, Life threatening, major and minor, Acces related complications, Renal or hepatic acute failure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>analysis of complications (Stroke, transient ischaemic attack, peripheral embolism, Pericardial effusion and tamponade Bleeding, Life threatening, major and minor, Acces related complications, Renal or hepatic acute failure) at 6 and 12 months</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3D printing</intervention_name>
    <description>Manufacturing and use of a model printed in 3D</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in atrial fibrillation addressed for percutaneous left atrial appendage closure
        intervention
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non valvular AF

          -  adressed for LAAC procedure

        Exclusion Criteria:

          -  opposition from patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vlad CIOBOTARU</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Privé Les Franciscaines</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas MOLINARI, PUPH</last_name>
    <phone>6 03 07 28 77</phone>
    <phone_ext>33</phone_ext>
    <email>n-molinari@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vlad CIOBOTARU, MD</last_name>
    <phone>614931165</phone>
    <phone_ext>33</phone_ext>
    <email>vciobotaru@yahoo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Privé les Franciscaines</name>
      <address>
        <city>Nîmes</city>
        <zip>30032</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>vlad CIOBOTARU, MD</last_name>
      <phone>614931165</phone>
      <phone_ext>33</phone_ext>
      <email>dr.ciobotaru.vlad@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2017</study_first_submitted>
  <study_first_submitted_qc>October 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LAAC</keyword>
  <keyword>3D printing</keyword>
  <keyword>Procedure success</keyword>
  <keyword>Procedure-related complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

